Key result
Severe resting gradient and basal hypertrophy in oHCM linked to ~98% higher mortality after ASA.
Why the study?
To investigate the short- and long-term efficiency of alcohol septal ablation across obstructive hypertrophic cardiomyopathy patient groups defined by baseline resting LVOT gradient and basal septal hypertrophy severity.
Does baseline LVOT gradient and basal septal hypertrophy severity affect long-term survival and reoperation rates after alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy?
Cohort (n=212)
Yes
Does baseline LVOT gradient and basal septal hypertrophy severity affect long-term survival and reoperation rates after alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy?
Answers are grounded in this paper and cite their sources.
In patients with obstructive hypertrophic cardiomyopathy undergoing alcohol septal ablation, the presence of both severe resting LVOT gradient and severe basal hypertrophy at baseline is associated with higher long-term mortality and reintervention rates.
The aim of this study was to investigate the short and long-term efficiency of alcohol septal ablation (ASA) in different groups of obstructive hypertrophic cardiomyopathy (oHCM) patients with severe and non-severe gradients in the left ventricle outflow tract (LVOT) and those with severe and non-severe basal septal hypertrophy. Material and methods. In this study, 212 oHCM patients were included. The mean age was 52±15. Female patients were 50.7% (107 patients). Patients were divided into 4 groups, according to the septal hypertrophy pattern and the severity of LVOT gradient at rest: group 0 – patients without severe LVOT gradient (<50 mmHg at rest) or severe basal hypertrophy (<20 mm); group 1 – patients with severe LVOT gradient (≥50 mmHg at rest), but without severe basal hypertrophy (<20 mm); group 2 – patients without severe LVOT gradient (<50 mmHg at rest), but with severe basal hypertrophy (≥20 mm); group 3 – patients with severe LVOT gradient (≥50 mmHg at rest) and with severe basal hypertrophy (≥20 mm). Results. The median follow-up was 74 (38–127) months. The long-term survival rates in entire cohort were as follows 98.1 (95% CI 96.2–100.0)%, 92.3 (95% CI 88.5–96.3)%, 77.2 (95% CI 70.1–85.0)%, at 1-, 5-, 10-years of follow-up. The cumulative incidence of mortality cases in the long-term was 41 patients (19.3%). The difference in survival rates between groups in this study did not reach the statistical significance (p=0.16), but comparing a group 3 (PG≥50 mmHg and IVS≥20 mm) with the rest of patients (PG <50 mmHg and/or IVS <20 mm) the statistically significant difference between survival rates was identified (p=0.029) with a hazard ratio (HR) = 1.98 (95% CI 1.06–3.72). The mean functional class of chronic heart failure improved from 2.5±0.6 to 1.5±0.6. In the follow-up, the LVOT gradient decreased from 60 (40–89) mmHg to 15 (9–124) mmHg at rest and from 108 (80–135) mmHg to 26 (16–49) mmHg after provocation. The mean IVS reduction was 5±3 mm in the follow-up. Residual obstruction was observed in 42 cases (20%) in the whole cohort. Comparing patients with PG≥50 mmHg with those with PG <50 mmHg the higher reoperation rates were observed in patients with the severe LVOT gradient at baseline [p=0.046, HR = 2.12 (95% CI 1.00–4.49)]. Conclusion. Alcohol septal ablation showed higher reintervention rates in cases with severe resting left ventricle outflow gradient at baseline. Patients with severe resting gradient and severe basal hypertrophy at baseline had higher long-term mortality rates despite the septal reduction.
No takes yet. Share an insight, caveat, or question.
Kashtanov et al. (2024) conducted a cohort in Obstructive hypertrophic cardiomyopathy (n=212). Severe LVOT gradient (≥50 mmHg) and severe basal hypertrophy (≥20 mm) at baseline vs. Non-severe LVOT gradient (<50 mmHg) and/or non-severe basal hypertrophy (<20 mm) at baseline was evaluated on Long-term mortality (HR 1.98, 95% CI 1.06-3.72, p=0.029). Patients with obstructive hypertrophic cardiomyopathy who had a severe resting gradient (≥50 mmHg) and severe basal hypertrophy (≥20 mm) at baseline had a higher risk of long-term mortality after alcohol septal ablation compared to those without both severe features.
Synapse has enriched 10 related papers. Consider them for comparative context: